Business Description
Solasia Pharma KK
ISIN : JP3436500007
Total Employee Number:
22Description
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors. The group consists of the company, consolidated subsidiary Solasia Medical Information Consulting (Shanghai) Co. Ltd., and a one-equity-method affiliate. The company is a specialty pharmaceutical company established with the purpose of developing and selling oncology drugs in Japan and other Asian countries, China, and South Korea, and has a portfolio of pharmaceutical and medical device products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.24 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 15.01 | |||||
Beneish M-Score | -1.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.9 | |||||
3-Year EBITDA Growth Rate | 34.2 | |||||
3-Year EPS without NRI Growth Rate | 39.6 | |||||
3-Year Book Growth Rate | -27 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 97.61 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.23 | |||||
9-Day RSI | 58.88 | |||||
14-Day RSI | 55.18 | |||||
3-1 Month Momentum % | -36.94 | |||||
6-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | -53.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.02 | |||||
Quick Ratio | 7.5 | |||||
Cash Ratio | 7.33 | |||||
Days Inventory | 3461.42 | |||||
Days Sales Outstanding | 1177.73 | |||||
Days Payable | 10384.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.2 | |||||
Shareholder Yield % | -13.61 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60 | |||||
Operating Margin % | -1823.33 | |||||
Net Margin % | -1900 | |||||
EBITDA Margin % | -1760 | |||||
FCF Margin % | -1017.51 | |||||
OCF Margin % | -1017.51 | |||||
ROE % | -39.28 | |||||
ROA % | -29.71 | |||||
ROIC % | -193.42 | |||||
3-Year ROIIC % | -94.54 | |||||
ROC (Joel Greenblatt) % | -503.69 | |||||
ROCE % | -36.08 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 204.55 | |||||
PB Ratio | 4.32 | |||||
Price-to-Tangible-Book | 4.03 | |||||
EV-to-EBIT | -10.78 | |||||
EV-to-EBITDA | -11.15 | |||||
EV-to-Revenue | 196.27 | |||||
EV-to-FCF | -19.24 | |||||
Price-to-GF-Value | 12.1 | |||||
| Price-to-Net-Current-Asset-Value | 6.05 | |||||
| Price-to-Net-Cash | 6.05 | |||||
Earnings Yield (Greenblatt) % | -9.28 | |||||
FCF Yield % | -4.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Solasia Pharma KK Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.177 | ||
| EPS (TTM) (€) | -0.013 | ||
| Beta | 2.454 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.06 | ||
| Volatility % | 60.3 | ||
| 14-Day RSI | 55.18 | ||
| 14-Day ATR (€) | 0.007131 | ||
| 20-Day SMA (€) | 0.1114 | ||
| 12-1 Month Momentum % | -53.74 | ||
| 52-Week Range (€) | 0.0935 - 0.242 | ||
| Shares Outstanding (Mil) | 273.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Solasia Pharma KK Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Solasia Pharma KK Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Solasia Pharma KK Frequently Asked Questions
What is Solasia Pharma KK(FRA:9SO)'s stock price today?
The current price of FRA:9SO is €0.12. The 52 week high of FRA:9SO is €0.24 and 52 week low is €0.09.
When is next earnings date of Solasia Pharma KK(FRA:9SO)?
The next earnings date of Solasia Pharma KK(FRA:9SO) is .
Does Solasia Pharma KK(FRA:9SO) pay dividends? If so, how much?
Solasia Pharma KK(FRA:9SO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Solasia Pharma KK
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers